Multiple HPV Infections and Cervical Lesion Risk
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how having multiple types of HPV virus affects the development of abnormal cervical cells (called CIN). It may help doctors understand why some people are more at risk and could lead to better prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a Pap smear that showed abnormal cells, and your doctor recommended a colposcopy or HPV test.
- You have an HPV-related growth on your vagina or vulva, or you have been diagnosed with cervical dysplasia (CIN) or early-stage cervical cancer (stage 1B or lower).
- You are not pregnant.
- You are 18 years or older.
- You have not had treatment for HPV-related vaginal, vulvar, or cervical lesions in the past 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies treatment approaches for conditions caused by human papillomavirus (HPV) in the female genital tract. It may help people whose HPV-related disease is being evaluated for new or combined treatment options.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.
This trial tests whether an HPV vaccine (Gardasil 9) can help women over 45 who still have HPV after treatment for a high-grade cervical lesion. It compares vaccinated and unvaccinated patients to see if vaccination lowers the risk of the lesion coming back.
This study looks at whether selenium levels in your body are linked to HPV and cervical changes. It may help us understand how to better prevent or treat cervical issues.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.